Search

Your search keyword '"Bipolar disorder -- Care and treatment"' showing total 1,560 results
Start Over Descriptor "Bipolar disorder -- Care and treatment"
1,560 results on '"Bipolar disorder -- Care and treatment"'

1. Researchers' Work from Purdue University Focuses on Affective Disorders (Affective Disorders and the Loudness Dependence of the Auditory Evoked Potential: Serotonin and Beyond)

Subjects
Bipolar disorder -- Care and treatment, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Mental health -- Health aspects, Phenols -- Health aspects, Depression, Mental -- Care and treatment, Physical fitness -- Health aspects, Serotonin -- Health aspects, Health, Purdue University
Abstract

2024 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Mental Health Diseases and Conditions - Affective [...]

Published
2024

2. Study Data from Deakin University Update Understanding of Bipolar Disorders (New Advances In the Pharmacology and Toxicology of Lithium: a Neurobiologically Oriented Overview)

Subjects
Bipolar disorder -- Care and treatment, Mental health -- Health aspects, Physical fitness -- Health aspects, Health, Deakin University
Abstract

2024 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Mental Health Diseases and Conditions - Bipolar [...]

Published
2024

3. Mental HEALTH DISORDERS HIGH AMONG COSMETIC PATIENTS

Subjects
Bipolar disorder -- Care and treatment, Mental health -- Reports -- Health aspects -- Surveys, Anxiety -- Care and treatment
Abstract

The survey highlighted an alarming link between mental health issues, such as anxiety and mood disorders, and the pursuit of cosmetic treatments, especially among younger individuals. The study found 59% [...]

Published
2024

4. Risperidone (generic) Risperdal (brand)

Subjects
Bipolar disorder -- Care and treatment, Schizophrenia -- Care and treatment, Child psychopathology -- Care and treatment, Risperidone, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health, Risperdal (Medication)
Abstract

Classification: Atypical antipsychotic. Common Usage: Risperidone is approved for the following uses: 1) treatment of schizophrenia in adults; 2) short-term treatment of acute mania or mixed episodes associated with bipolar [...]

Published
2024

5. Aripiprazole (generic) Abilify (brand)

Subjects
Bipolar disorder -- Care and treatment, Aripiprazole, Antidepressants, Schizophrenia -- Care and treatment, Child psychopathology -- Care and treatment, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health
Abstract

Classification: Atypical antipsychotic. Common usage: Aripiprazole is indicated for the treatment of adults with schizophrenia and acute manic and mixed episodes associated with bipolar I disorder, and for maintaining efficacy [...]

Published
2024

6. MANAGING BIPOLAR DISORDER: Personalization and Education Are Key

Author

Loria, Keith

Subjects
Bipolar disorder -- Care and treatment, Patient compliance, Company business management, Business, Pharmaceuticals and cosmetics industries
Abstract

Bipolar disorder is a lifelong illness with significant risks of relapse that can have detrimental consequences for the individual and their families or caregivers. When treating patients with bipolar disorder, [...]

Published
2023

7. Becoming Comfortable With Discomfort: Polypharmacy for Patients With Substance Use Disorders

Author

Shenoi, Nancy

Subjects
Bipolar disorder -- Care and treatment, Patient compliance -- Health aspects, Lung diseases, Obstructive -- Care and treatment, Smoking -- Care and treatment, Post-traumatic stress disorder -- Care and treatment, Acamprosate -- Health aspects, Substance abuse -- Care and treatment, Health, Psychology and mental health, Care and treatment, Health aspects
Abstract

CASE STUDY During an intake evaluation, 32-year-old 'Mark' was diagnosed with posttraumatic stress disorder, bipolar disorder, severe alcohol use disorder, severe opioid use disorder (OUD), severe tobacco use disorder, and [...]

Published
2024

9. University Hospitals Cleveland Medical Center Researcher Reports Recent Findings in Bipolar Disorders (Possible Role of Correlation Coefficients and Network Analysis of Multiple Intracellular Proteins in Blood Cells of Patients with Bipolar ...)

Subjects
Bipolar disorder -- Care and treatment, Medical research -- Reports, Medicine, Experimental -- Reports, Medical centers -- Reports, Proteins -- Reports, Physical fitness -- Reports, Health
Abstract

2024 MAR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on bipolar disorders. According to news reporting originating [...]

Published
2024

10. Asenapine (generic): Saphris (brand)

Subjects
Bipolar disorder -- Care and treatment, Dementia -- Care and treatment, Stroke (Disease) -- Care and treatment, Schizophrenia -- Care and treatment, Asenapine, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health
Abstract

Classification: Atypical antipsychotic. Common usage: Asenapine is indicated for the treatment of schizophrenia in adults, and for the acute treatment of manic or mixed episodes associated with bipolar I disorder [...]

Published
2024

11. Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder

Subjects
Care and treatment, Product development, Depression (Mood disorder) -- Care and treatment, Clinical trials, Bipolar disorder -- Care and treatment, Depression, Mental -- Care and treatment
Abstract

AMPLIFY 230-patient trial aims to improve on efficacy and safety established with thyroid hormone as an adjunctive treatment for MDD; topline data expected in the second half of 2025 ABX-002 [...]

Published
2024

12. NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

Subjects
Bipolar disorder -- Care and treatment, Depression, Mental -- Care and treatment, Clinical psychiatry, Business, News, opinion and commentary
Abstract

'How NRx Could Upend the Fight Against Depression and Suicide' RADNOR, Pa., Sept. 11, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, ('NRx,' the 'Company'), today [...]

Published
2024

13. Thinking Beyond the Guidelines: Evidence-Based Novel Therapies for Bipolar Depression

Author

Hardy, Lyons and McCarthy, Brian

Subjects
Bipolar disorder -- Care and treatment, Practice guidelines (Medicine), Lamotrigine, Evidence-based medicine, Health, Psychology and mental health
Abstract

(This is the second part of a 2-part article discussing novel treatments for bipolar depression. Part 1 appeared in the September issue and discussed the need for novel treatments for [...]

Published
2022

17. Vancouver mother wants to know: What has happened to my mentally ill son?

Subjects
Bipolar disorder -- Care and treatment, Mentally ill -- Care and treatment, Psychiatric hospital care, Psychiatric hospitals, Missing persons, Business, General interest, Business, regional
Abstract

Byline: Alexis Weisend May 3Jacques Le'Sueur's phone calls to his family stopped a year ago when Clark County sent him to Western State Hospital, a psychiatric facility 130 miles away. [...]

Published
2024

18. Risperidone long-acting injectable (generic): Risperdal Consta (BRAND)

Subjects
Bipolar disorder -- Care and treatment, Dementia -- Care and treatment, Ropinirole, Schizophrenia -- Care and treatment, Pramipexole, Risperidone, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health, Risperdal Consta (Medication)
Abstract

Classification: Atypical antipsychotic. Common usage: Risperidone long-acting injectable (LAI) is approved for treating schizophrenia. It is also approved for treating bipolar I disorder, either alone or together with lithium or [...]

Published
2024

19. Desvenlafaxine extended release (generic): Pristiq (BRAND)

Subjects
Bipolar disorder -- Care and treatment, Antidepressants, Child psychopathology -- Care and treatment, Depression, Mental -- Care and treatment, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health
Abstract

Classification: Serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant. Common usage: Desvenlafaxine extended release is indicated for treating major depressive disorder. Desvenlafaxine is not approved for treating depression in bipolar disorder. Desvenlafaxine is [...]

Published
2023

20. Data from Warsaw University of Life Sciences Advance Knowledge in Bipolar Disorders (Pro/antioxidant status and selenium, zinc and arsenic concentration in patients with bipolar disorder treated with lithium and valproic acid)

Subjects
Bipolar disorder -- Care and treatment, Medical research, Medicine, Experimental, Selenium, Mental health, Zinc, Valproic acid, Divalproex, Arsenic
Abstract

2024 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A new study on bipolar disorders is now available. According to news originating [...]

Published
2024

21. Data from Santa Casa de Sao Paulo School of Medical Sciences Broaden Understanding of Bipolar Disorders (The anti-anhedonic effects of ketamine in the treatment of resistant unipolar and bipolar depression: A systematic review and meta-analysis ...)

Subjects
Bipolar disorder -- Care and treatment, Mental health -- Reports, Health, Psychology and mental health
Abstract

2024 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Investigators publish new report on bipolar disorders. According to news reporting originating from [...]

Published
2024

22. University of New South Wales Researcher Describes Research in Bipolar Disorders (Factors associated with electroconvulsive therapy treatment for adults with serious psychiatric conditions in Australia)

Subjects
Bipolar disorder -- Care and treatment, Medical research, Medicine, Experimental, Mental health, Adults, Health, Psychology and mental health
Abstract

2024 AUG 12 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Fresh data on bipolar disorders are presented in a new report. According to [...]

Published
2024

23. Investigators at New York Medical College Describe Findings in Bipolar Disorders (Effects of Cariprazine On Reducing Symptoms of Irritability, Hostility, and Agitation In Patients With Manic or Mixed Episodes of Bipolar I Disorder)

Subjects
New York Medical College -- Reports, Bipolar disorder -- Care and treatment, Medical research -- Analysis -- Reports, Medicine, Experimental -- Analysis -- Reports, Mental health -- Reports -- Analysis, Mania -- Care and treatment
Abstract

2024 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A new study on Mental Health Diseases and Conditions - Bipolar Disorders is […]

Published
2024

24. Autobahn Therapeutics Completes Oversubscribed $100 Million Series C Financing to Advance Pipeline of Novel Therapeutics for Depression and Other CNS Disorders

Subjects
Canaan Partners, Insight Partners, Bipolar disorder -- Care and treatment, Depression, Mental -- Care and treatment, Venture capital companies, Business, Business, international
Abstract

Advancing ABX-002, a highly potent, selective and centrally active thyromimetic, into Phase 2 clinical trials for patients with major depressive disorder and bipolar disorder depression Advancing neuroimmunology candidate, ABX-101, a [...]

Published
2024

25. AANA Issues Updated Practice Considerations for Ketamine Therapy for Psychiatric Disorders and Chronic Pain Management

Subjects
Bipolar disorder -- Care and treatment, Ketamine -- Analysis, Chronic pain -- Care and treatment, Post-traumatic stress disorder -- Care and treatment, Pain -- Care and treatment, Evidence-based medicine -- Analysis, Registered nurses -- Analysis, Business, News, opinion and commentary
Abstract

ROSEMONT, Ill., May 28, 2024 /PRNewswire/ -- The American Association of Nurse Anesthesiology (AANA) recently updated its https://c212.net/c/link/?t=0&l=en&o=4176700-1&h=3440475079&u=https%3A%2F%2Fissuu.com%2Faanapublishing%2Fdocs%2F7_-_ketamine_infusion_therapy_for_psychiatric_diso%3Ffr%3DsNTFhMjU2NDAxMjU&a=practice+considerations addressing ketamine therapy to cite the most current studies, as AANA continues [...]

Published
2024

26. Alzamend Neuro Announces Initial Closing of Private Placement

Subjects
Bipolar disorder -- Care and treatment, Private placements (Securities), Capital stock, Post-traumatic stress disorder -- Care and treatment, Alzheimer's disease -- Care and treatment, Preferred stocks, Business, Business, international
Abstract

* Investor had agreed to purchase up to $25 million of preferred shares * Alzamend expects to use proceeds to further its clinical trials and working capital purposes ATLANTA -- [...]

Published
2024

28. Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million

Subjects
United States. Securities and Exchange Commission, Bipolar disorder -- Care and treatment, Private placements (Securities), Convertible preferred stocks, Post-traumatic stress disorder -- Care and treatment, Alzheimer's disease -- Care and treatment, Business, Business, international
Abstract

ATLANTA -- Alzamend Neuro, Inc. (Nasdaq: ALZN) ('Alzamend'), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ('Alzheimer's'), bipolar disorder ('BD'), major depressive disorder [...]

Published
2024

29. Study Results from Postgraduate Institute of Medical Education and Research Update Understanding of Drug Abuse [Prevalence and Association of Comorbid Substance Dependence On the Course and Outcome of Bipolar Disorder: Findings From the Bipolar ...]

Subjects
Bipolar disorder -- Care and treatment, Comorbidity -- Care and treatment, Medical personnel -- Training, Education -- India, Drug abuse -- Care and treatment, Physical fitness, Health
Abstract

2023 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Opioids is the subject of a report. According to [...]

Published
2023

30. Limited evidence of autocorrelation signaling upcoming affective episodes: a 12-month e-diary study in patients with bipolar disorder (Updated June 20, 2024)

Subjects
Bipolar disorder -- Care and treatment, Medical research -- Analysis, Medicine, Experimental -- Analysis, Mental health -- Analysis, Health, Psychology and mental health
Abstract

2024 JUL 8 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

31. Evidence for mood instability in patients with bipolar disorder: Applying multilevel hidden Markov modelling to intensive longitudinal ecological momentary assessment data (Updated June 20, 2024)

Subjects
Bipolar disorder -- Care and treatment, Markov processes -- Analysis, Health, Psychology and mental health
Abstract

2024 JUL 8 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

32. Data from University of Southern California (USC) Advance Knowledge in Bipolar Disorders [Lift (A Lithium Fiber-based Test): an At-home Companion Diagnostics for a Safer Lithium Therapy In Bipolar Disorder]

Subjects
United States. National Institutes of Health, Bipolar disorder -- Care and treatment, Mental health -- Health aspects, Health, Psychology and mental health, University of Southern California
Abstract

2024 JUN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Investigators publish new report on Mental Health Diseases and Conditions - Bipolar Disorders. [...]

Published
2024

33. Reports from Southern Medical University Advance Knowledge in Personalized Medicine (Retrospective Analysis of Steady-State Sodium Valproate Plasma Concentrations in Chinese Patients With Bipolar Disorder: Impact of Demographic and Clinical ...)

Subjects
Bipolar disorder -- Care and treatment, Mental health, Valproic acid, Medical colleges, Divalproex, Health, Psychology and mental health
Abstract

2024 MAY 6 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Researchers detail new data in personalized medicine. According to news reporting out of [...]

Published
2024

34. Bipolar disorder: Raising awareness

Subjects
Bipolar disorder -- Care and treatment, News, opinion and commentary, Sports and fitness
Abstract

Post Views: 5 By Isa Riano, Advertisement Manager Considering World Bipolar Day, which takes place on March 30 of every year, it is vital to raise awareness of bipolar disorder, [...]

Published
2024

35. Talkiatry Celebrates One Million Patient Visits

Subjects
Bipolar disorder -- Care and treatment, Health care reform, Mental health, Attention-deficit hyperactivity disorder -- Care and treatment, Psychiatric services, General interest, News, opinion and commentary
Abstract

NEW YORK: Talkiatry has issued the following news release: Talkiatry, a leading provider of high-quality, in-network psychiatric care, today announced it has reached one million patient visits since its 2020 [...]

Published
2024

40. Adjunctive dextromethorphan/quinidine promising in pilot study for depression

Subjects
Bipolar disorder -- Care and treatment, Depression, Mental -- Care and treatment, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health
Abstract

The delayed effects of first-line treatments for depression have led investigators to search for more rapid-acting therapies. Investigators conducted an open-label pilot study to evaluate the efficacy and tolerability of [...]

Published
2024

41. University of New South Wales Researcher Publishes New Studies and Findings in the Area of Bipolar Disorders (Phase-based concerns of caregivers for individuals with a bipolar disorder)

Subjects
Bipolar disorder -- Care and treatment, Medical research, Medicine, Experimental, Caregivers, Physical fitness, Health
Abstract

2023 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in bipolar disorders. According to news reporting out [...]

Published
2023

42. Studies from Bioaraba Health Research Institute Have Provided New Data on Personalized Medicine (Lithium levels and lifestyle in patients with bipolar disorder: a new tool for self-management)

Subjects
Bipolar disorder -- Care and treatment, Exercise, Medical research, Medicine, Experimental, Physical fitness, Health
Abstract

2023 APR 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on personalized medicine. According to news originating from [...]

Published
2023

44. Intra-Cellular reports positive results from Study 403 evaluating lumateperone as monotherapy in patients with MDD with mixed features and bipolar depression with mixed features

Subjects
Bipolar disorder -- Care and treatment, Pharmaceuticals and cosmetics industries
Abstract

Intra-Cellular Therapies, Inc., a biopharmaceutical company, announced positive topline results from Study 403 evaluating lumateperone 42mg as monotherapy in the treatment of major depressive episodes in patients with major depressive [...]

Published
2023

45. Olanzapine (generic)

Subjects
Bipolar disorder -- Care and treatment, Schizophrenia -- Care and treatment, Olanzapine, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health, Zyprexa (Medication)
Abstract

Classificatin: Atypical antipsychotic. Common Usage: Oral olanzapine is indicated for the treatment of schizophrenia and for the short-term treatment of acute manic or mixed episodes associated with bipolar disorder in [...]

Published
2023

46. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b|3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

Subjects
Bipolar disorder -- Care and treatment, Suicidal behavior -- Care and treatment, Clinical trials, General interest, News, opinion and commentary
Abstract

RADNOR, Pa: NRx Pharmaceuticals has issued the following news release: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', the 'Company'), a clinical-stage biopharmaceutical company, today announced completion of enrollment in its [...]

Published
2024

47. Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI (olanzapine and samidorphan)

Subjects
Bipolar disorder -- Care and treatment, Body weight -- Safety and security measures, Schizophrenia -- Care and treatment, Olanzapine -- Labeling, Business, News, opinion and commentary
Abstract

- Results Demonstrated that LYBALVI was Generally Well Tolerated With Stability of Body Weight and Metabolic Profile, and Durable Symptom Control, for Up to Four Years of Treatment - DUBLIN, [...]

Published
2024

48. Differential Serum Levels of CACNA1C, Circadian Rhythm and Stress Response Molecules in Subjects with Bipolar Disorder: Associations with Genetic and Clinical Factors

Subjects
Bipolar disorder -- Care and treatment, Genetic research, Mental health, Health, Psychology and mental health
Abstract

2024 APR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

49. Electroconvulsive therapy ECT shown to reduce severity of certain mental illnesses

Subjects
Bipolar disorder -- Care and treatment, Mental health, Depression, Mental -- Care and treatment, Health, Psychology and mental health
Abstract

2024 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Researchers have found that Electroconvulsive Therapy (ECT), where an electric current is passed [...]

Published
2024

50. Findings from Ardakan University in Borderline Personality Disorder Reported (The comparison of hot and cold executive functions in patients with bipolar II disorder, borderline personality disorder, and healthy individuals)

Subjects
Bipolar disorder -- Care and treatment, Mental health -- Comparative analysis, Borderline personality disorder -- Care and treatment, Health, Psychology and mental health
Abstract

2024 APR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Data detailed on borderline personality disorder have been presented. According to news reporting [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results